Literature DB >> 2463681

Surgical treatment of advanced carcinoma of the esophagus.

S Abe1, M Tachibana, T Shimokawa, M Shiraishi, T Nakamura.   

Abstract

This report was done to evaluate the role of surgical treatment of locally advanced carcinoma of the esophagus. All 32 patients had histologically proved epidermoid carcinomas of the esophagus. The post-operative one and two year survival rates and median survival time were 34.6 and 17.3 per cent and 199 days for those in the group undergoing esophagectomy, zero per cent and 55 days for those in the group with bypass and zero per cent and 80 days for those undergoing formation of a stoma. Thirty day postoperative mortality rates were zero per cent for the esophagectomy group, 25.0 per cent for the stoma group and 33.3 per cent for the bypass group. When calculated from the date of diagnosis, the one and two year survival rates and the median survival time were 50.2 and 16.7 per cent and 296 days for the esophagectomy group, 16.7 and zero per cent and 196 days for the bypass group, 25.0 and zero per cent and 142 days for the stoma group and zero per cent and 142 days for the group who did not undergo surgical treatment. Complication related postoperative deaths occurred in 14.8 per cent of the 27 patients operated upon. For those in the esophagectomy group, it was 5.9 per cent, and for the bypass group, 50.0 per cent. Swallowing was improved in 58.8 per cent after esophagectomy, but in none of the patients was swallowing restored after the bypass procedures. When the invasion spared the aorta or major respiratory tract, postoperative survival time after esophagectomy was significantly better. Considering the short postoperative survival time and frequent complications, bypass procedure should not be the final resort after nonsurgical treatment.

Entities:  

Mesh:

Year:  1989        PMID: 2463681

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  5 in total

1.  Assessment of adventitial involvement of esophageal carcinoma by endoscopic ultrasonography.

Authors:  H Date; M Miyashita; K Sasajima; M Toba; K Yamashita; K Takubo; M Onda
Journal:  Surg Endosc       Date:  1990       Impact factor: 4.584

Review 2.  Comparison of different treatments for unresectable esophageal cancer.

Authors:  C E Reed
Journal:  World J Surg       Date:  1995 Nov-Dec       Impact factor: 3.352

3.  Concordance of clinical diagnosis of T classification among physicians for locally advanced unresectable thoracic esophageal cancer.

Authors:  Tomoya Yokota; Takushi Yasuda; Hiroyuki Kato; Isao Nozaki; Hiroshi Sato; Yoshinori Miyata; Yoshifumi Kuroki; Ken Kato; Yasuo Hamamoto; Yasuhiro Tsubosa; Hirofumi Ogawa; Yoshinori Ito; Yuko Kitagawa
Journal:  Int J Clin Oncol       Date:  2017-07-25       Impact factor: 3.402

4.  Accuracy of preoperative diagnosis of lymph node metastasis for thoracic esophageal cancer patients from JCOG9907 trial.

Authors:  Tomoya Yokota; Hiroyasu Igaki; Ken Kato; Yasuhiro Tsubosa; Junki Mizusawa; Hiroshi Katayama; Kenichi Nakamura; Haruhiko Fukuda; Yuko Kitagawa
Journal:  Int J Clin Oncol       Date:  2015-09-03       Impact factor: 3.402

5.  Endoscopic palliation of malignant dysphagia: a challenging task in inoperable oesophageal cancer.

Authors:  I E Katsoulis; A Karoon; S Mylvaganam; J I Livingstone
Journal:  World J Surg Oncol       Date:  2006-07-04       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.